Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients
Autor: | Vanessa J Xavier, Geert J.L.H. van Leenders, Dorien J.M. Peters, Paul C.M.S. Verhagen, Annelies de Klein, Bert Eussen, Job van Riet, Annegien Kenter, Ruben Boers, Harmen J.G. van de Werken, Joost Gribnau, Robert Zietse, Marjan E van Til, Joachim Boers, Gert Jansen, Mehrnaz Ghazvini, Wilfred F. J. van IJcken, Monique Losekoot, Eveline Rentmeester, Ewout J. Hoorn |
---|---|
Přispěvatelé: | Cell biology, Developmental Biology, Internal Medicine, Urology, Pathology, Clinical Genetics |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
DNA Mutational Analysis PKD1 Kidney urologic and male genital diseases Epigenesis Genetic 0302 clinical medicine Polycystic kidney disease somatic mutation Induced pluripotent stem cell lcsh:R5-920 DNA methylation lcsh:Cytology epigenetic memory General Medicine Cellular Reprogramming Polycystic Kidney Autosomal Dominant female genital diseases and pregnancy complications 3. Good health iPS cells Kidney Tubules medicine.anatomical_structure lcsh:Medicine (General) Reprogramming Pluripotent Stem Cells TRPP Cation Channels Induced Pluripotent Stem Cells Biology Cell Line 03 medical and health sciences Germline mutation medicine second hit Humans lcsh:QH573-671 ADPKD cyst urogenital system Epithelial Cells Cell Biology medicine.disease renal epithelial cells 030104 developmental biology Mutation Cancer research 030217 neurology & neurosurgery Developmental Biology Kidney disease |
Zdroj: | Stem Cells Translational Medicine, 9(4), 478-490. WILEY Stem cells translational medicine, 9(4), 478-490. John Wiley & Sons Ltd. Stem Cells Translational Medicine Stem Cells Translational Medicine, Vol 9, Iss 4, Pp 478-490 (2020) |
ISSN: | 2157-6564 |
Popis: | Autosomal‐dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, leading to kidney failure in most patients. In approximately 85% of cases, the disease is caused by mutations in PKD1. How dysregulation of PKD1 leads to cyst formation on a molecular level is unknown. Induced pluripotent stem cells (iPSCs) are a powerful tool for in vitro modeling of genetic disorders. Here, we established ADPKD patient‐specific iPSCs to study the function of PKD1 in kidney development and cyst formation in vitro. Somatic mutations are proposed to be the initiating event of cyst formation, and therefore, iPSCs were derived from cystic renal epithelial cells rather than fibroblasts. Mutation analysis of the ADPKD iPSCs revealed germline mutations in PKD1 but no additional somatic mutations in PKD1/PKD2. Although several somatic mutations in other genes implicated in ADPKD were identified in cystic renal epithelial cells, only few of these mutations were present in iPSCs, indicating a heterogeneous mutational landscape, and possibly in vitro cell selection before and during the reprogramming process. Whole‐genome DNA methylation analysis indicated that iPSCs derived from renal epithelial cells maintain a kidney‐specific DNA methylation memory. In addition, comparison of PKD1+/− and control iPSCs revealed differences in DNA methylation associated with the disease history. In conclusion, we generated and characterized iPSCs derived from cystic and healthy control renal epithelial cells, which can be used for in vitro modeling of kidney development in general and cystogenesis in particular. Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. Here, we generated induced pluripotent stem cells (iPSCs) of ADPKD patients to study kidney development and cyst formation in vitro. These iPSCs revealed germline and autosomal mutations implicated in ADPKD and displayed an epigenetic memory of kidney epithelial cells, providing powerful models to study ADPKD in vitro. |
Databáze: | OpenAIRE |
Externí odkaz: |